
BPC-157: where the evidence stops
Why experimental data on BPC-157 cannot replace clinical trials, and which questions remain open.
Research, limitations and safety questions.
A substance's popularity among athletes does not demonstrate its effectiveness. We look at who was studied and why anti-doping status needs to be checked separately.

Why experimental data on BPC-157 cannot replace clinical trials, and which questions remain open.

Why a change in a hormone measurement does not establish better recovery or athletic performance.

How to match a trade name, a molecule and a study without transferring conclusions between different substances.